Patents by Inventor Yaopeng ZHAO

Yaopeng ZHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11609257
    Abstract: An experimental device for tripping properties of a high-voltage transmission line in a smoldering atmosphere, including a central information processor, a biomass fuel (BMF) property characterization module, a smoldering generation module, a smoldering smoke field property test module, a power frequency supply module and a tripping property test module. The experimental device and method for tripping properties of a high-voltage transmission line in a smoldering atmosphere, the present disclosure can explore the development conditions, processes, modes, properties and mechanisms of discharge in the smoldering atmosphere, and fully characterize the BMF such as forest vegetations from multiple aspects, to reproduce properties of forest vegetations in corridor areas of the high-voltage transmission line in multiple working conditions and reflect influences of properties of ground forest vegetations on the tripping properties of the high-voltage transmission lines.
    Type: Grant
    Filed: February 24, 2022
    Date of Patent: March 21, 2023
    Assignee: Nanjing Tech University
    Inventors: Fei You, Zhiliang Xu, Sheng Wang, Zhenhua Wang, Kai Shui, Yaopeng Zhao, Siyi Chen
  • Publication number: 20220291272
    Abstract: An experimental device for tripping properties of a high-voltage transmission line in a smoldering atmosphere, including a central information processor, a biomass fuel (BMF) property characterization module, a smoldering generation module, a smoldering smoke field property test module, a power frequency supply module and a tripping property test module. The experimental device and method for tripping properties of a high-voltage transmission line in a smoldering atmosphere, the present disclosure can explore the development conditions, processes, modes, properties and mechanisms of discharge in the smoldering atmosphere, and fully characterize the BMF such as forest vegetations from multiple aspects, to reproduce properties of forest vegetations in corridor areas of the high-voltage transmission line in multiple working conditions and reflect influences of properties of ground forest vegetations on the tripping properties of the high-voltage transmission lines.
    Type: Application
    Filed: February 24, 2022
    Publication date: September 15, 2022
    Inventors: Fei You, Zhiliang Xu, Sheng Wang, Zhenhua Wang, Kai Shui, Yaopeng Zhao, Siyi Chen
  • Patent number: 11274079
    Abstract: The disclosure relates to a 2-(2,2-diarylethyl)-cyclic amine derivative or salt, a synthesis method, an application and a composition thereof. Biological activity test shows that this kind of 2-(2,2-diarylethyl)-cyclic amine derivative has good M-receptor antagonistic activity; and can be used as an active component of drugs for the treatment of the diseases mediated or regulated by muscarinic receptors, such as asthma, chronic obstructive pulmonary disease (COPD), overactive bladder (OAB), bronchospasm with chronic obstructive pulmonary disease, visceral spasm, irritable bowel syndrome, Parkinson's disease, depression or anxiety, schizophrenia and related mental diseases.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: March 15, 2022
    Assignee: Dalian Institute of Chemical Physics, Chinese Academy of Sciences
    Inventors: Xinmiao Liang, Yaopeng Zhao, Yanfang Liu, Jixia Wang, Changjian Wang, Zhiwei Wang, Nana Du, Xiuli Zhang, Zhimou Guo, Chaoran Wang
  • Publication number: 20210155591
    Abstract: The disclosure relates to a 2-(2,2-diarylethyl)-cyclic amine derivative or salt, a synthesis method, an application and a composition thereof. Biological activity test shows that this kind of 2-(2,2-diarylethyl)-cyclic amine derivative has good M-receptor antagonistic activity; and can be used as an active component of drugs for the treatment of the diseases mediated or regulated by muscarinic receptors, such as asthma, chronic obstructive pulmonary disease (COPD), overactive bladder (OAB), bronchospasm with chronic obstructive pulmonary disease, visceral spasm, irritable bowel syndrome, Parkinson's disease, depression or anxiety, schizophrenia and related mental diseases.
    Type: Application
    Filed: April 11, 2019
    Publication date: May 27, 2021
    Inventors: Xinmiao LIANG, Yaopeng ZHAO, Yanfang LIU, Jixia WANG, Changjian WANG, Zhiwei WANG, Nana DU, Xiuli ZHANG, Zhimou GUO, Chaoran WANG